Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the...

cafead

Administrator
Staff member
  • cafead   Jun 22, 2022 at 10:52: AM
via New assay brings validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression

article source
 

<